PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links


Article published in Urologia Polska 1998/51/1.

authors

Romuald Zdrojowy
Katedra i Klinika Urologii AM we Wrocławiu
Kierownik Kliniki: prof. dr hab. med. J. Lorenz

references

  1. [1] Boyce, N.: When is testing for free PSA beneficial? Clin. Lab. News 1997,
  2. 23, 1-3.
  3. [2] Catalona, W. J., Colberg, J. W., Smith, D. S., Ornstein, D. K., Shayka, J.
  4. J.: Measurement of percent-free PSA improves specifity for lower PSA cu-
  5. toffs in prostate cancer screening. J. Urol. 1996, 155, supl., 422A.
  6. [3] Catalona, W. J., Smith, D. S., Wolfert, R. L., Wang, T. J., Rittenhouse, H. G.,
  7. Ratliff, T. L.: Evaluation of percentage of free serum prostate specific antigen
  8. to improve specifity of prostate cancer screening. JAMA, 1995,46,187-194.
  9. [4] Haese, A., Graefen, M., Noldus,}., Hammerer, P, Huland, E., Huland, H.:
  10. Prostatic volume and ratio of free-to-total prostate specific antigen in patients
  11. with prostatic cancer or benign prostatic hyperplasia. J. Urol. 1997,158,2188-
  12. -2192.
  13. [5] Hudson, M. A., Bahnson, R. R., Catalona, W. J.: Clinical use of prostate
  14. specific antigen in patients with prostate cancer. J. Urol. 1989,142,1011-1017.
  15. [6] Keetch, D. W., Catalona, W. ]., Smith, D. S.: Serial prostatic biopsies in men
  16. with persistently elevated serum prostate specific antigen values. J. Urol. 1994,
  17. 151, 1571-1574.
  18. [7] Lange, P. H., Ercole, C. J., Lightner, D. J., Fraley, E. E., Vessella, R.: The
  19. value of serum prostate specific antigen determinations before and after radi-
  20. cal prostatectomy. J. Urol. 1989,141, 873-879.
  21. [8] Morote, ]., Raventos, C. X., Lorente, J.A., Lopez-Pacios, M. A., Encabo, G.,
  22. de Torres, I., Andreu, J.: Comparison of percent free prostate specific antigen
  23. and prostate specific antigen density as methods to enhance prostate specific
  24. antigen specifity in early prostate cancer detection in men with normal rectal
  25. examination and prostate specific antigen between 4.1 and 10 ng/ml. J. Urol.
  26. 1997, 158, 502-504.
  27. [9] Oesterling, J. E.: Free, complexed and total serum prostate specific antigen:
  28. the establishment of appropriate reference ranges for their concentrations and
  29. ratios. J. Urol. 1995,154,1090-1095.
  30. [10] Smith, J. A., Middleton, R. G.: Clinical management of prostatic cancer. Year
  31. Book Medical Publishers, Inc, Chicago, London, Boca Raton, 1987,85-86.
  32. [11] Vashi, A. R., Oesterling, J. E.: Percent free Prostate-specific antigen: entering
  33. a new era in the detection of prostate cancer. Mayo Clin. Proc. 1997, 72,337-
  34. -344.
  35. [12] Zdrojowy, R.: Historia naturalna. Choroby gruczołu krokowego, pod red.
  36. A. Borkowskiego, A. Borówki. PZWL, Warszawa 1997, 234-243.